Fortress Biotech, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Highbridge Capital Management, LLC has filed a Schedule 13G, reporting beneficial ownership of 7.8% of Fortress Biotech, Inc. common stock, primarily through warrants.